U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 20, 2005
Diagnostic Products Corporation
(Exact name of Registrant as specified in its charter)
California 1-9957 95-2802182
---------- ------ ----------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
5210 Pacific Concourse Drive, Los Angeles, California 90045
- -------------------------------------------------------------- --------
(Address of principal executive offices) (Zip Code)
(310) 725-7039
-------------------------------------------------------
(Registrant's telephone number, including area code)
N/A
-------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Diagnostic Products Corporation
Current Report on Form 8-K
ITEM 7.01. Regulation FD Disclosure.
On May 20, 2005, Diagnostic Products Corporation announced
settlements with the Securities and Exchange Commission and
U.S. Department of Justice relating to their investigations of
issues related to its Chinese subsidiary's compliance with the
U.S. Foreign Corrupt Practices Act. A copy of DPC's press
release is filed as Exhibit 99.1 to this Form 8-K and is
incorporated herein by this reference in its entirety.
ITEM 8.01 Other Events.
On May 20, 2005, Diagnostic Products Corporation announced
settlements with the Securities and Exchange Commission and
U.S. Department of Justice relating to their investigations of
issues related to its Chinese subsidiary's compliance with the
U.S. Foreign Corrupt Practices Act. A copy of DPC's press
release is filed as Exhibit 99.1 to this Form 8-K and is
incorporated herein by this reference in its entirety.
ITEM 9.01 Financial Statements and Exhibits.
(c) Exhibits
99.1 - Press Release dated May 20, 2005.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: May 20, 2005 DIAGNOSTIC PRODUCTS CORPORATION
By: /s/ James L. Brill
---------------------------------------
James L. Brill,
Vice President, Finance
2
Exhibit Index
99.1 - Press Release dated May 20, 2005.
3